SLC5A5 and neoplasm: For successful implementation of endogenous NIS mediated gene therapy approach, the major bottlenecks are insufficient radioiodide accumulation in the tumor bed as well as short tracer retention time, putting a question mark on adequate therapeutic value of this approach.